These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33628340)

  • 1. Serum Levels of BDNF in Patients with Adenoma and Colorectal Cancer.
    Wang Z; Wang S; Liu Y; Gao S; Yu Y; Hu Z
    Dis Markers; 2021; 2021():8867368. PubMed ID: 33628340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patients.
    Brierley GV; Priebe IK; Purins L; Fung KY; Tabor B; Lockett T; Nice E; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Burgess A; Cosgrove LJ
    Cancer Biomark; 2013; 13(2):67-73. PubMed ID: 23838134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Pasha HF; Radwan MI; Yehia AM; Toam MM
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.
    Xie H; Guo JH; An WM; Tian ST; Yu HP; Yang XL; Wang HM; Guo Z
    World J Gastroenterol; 2017 Mar; 23(12):2159-2167. PubMed ID: 28405143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.
    Naicker YD; Moolla Z; Madiba T
    Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
    Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
    Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SALL4 as a new biomarker for early colorectal cancers.
    Ardalan Khales S; Abbaszadegan MR; Abdollahi A; Raeisossadati R; Tousi MF; Forghanifard MM
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):229-35. PubMed ID: 25156818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
    PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.
    Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R
    Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
    Wang Q; Zhang H; Shen X; Ju S
    Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.